• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $PFNX

    Pfenex Inc.

    Subscribe to $PFNX
    $PFNX
    Major Pharmaceuticals
    Health Care

    IPO Year: 2014

    Exchange: AMEX

    Recent Analyst Ratings for Pfenex Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Pfenex Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed

      SC 13G/A - Pfenex Inc. (0001478121) (Subject)

      2/11/21 3:24:16 PM ET
      $PFNX
      Major Pharmaceuticals
      Health Care

    Pfenex Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Pipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors

      Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for precision neuroregeneration, today announced the appointment of Evert (Eef) Schimmelpennink to its Board of Directors. Mr. Schimmelpennink is a seasoned biotechnology executive with close to 25 years of experience spanning research and development, commercial growth, manufacturing, and business development. "I am pleased to welcome Eef Schimmelpennink to Pipeline's Board of Directors," said Carmine Stengone, President and Chief Executive Officer of Pipeline Therapeutics. "Eef is a renowned leader in the life-sciences industry whose cross-functional leade

      2/15/22 8:00:00 AM ET
      $IBIO
      $PFNX
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Major Pharmaceuticals
    • TransCode Therapeutics Announces Key Appointments

      BOSTON--(BUSINESS WIRE)--TransCode Therapeutics today announced that it has recently elected a Chairman of its Board of Directors, appointed two new Independent Directors to the Board, and appointed a new member to its Advisory Board. Philippe Calais, Pharm D, Ph.D., President, Chief Executive Officer and a director of MatriSys Bioscience, Inc., has been elected Chairman of the Board of Directors of TransCode. Dr. Calais has served on TransCode’s Board of Directors since October 2018. With an extensive background in drug development, Dr. Calais’ experience has been instrumental in advancing TransCode’s lead therapeutic candidate, TTX-MC138, focused on treating metastatic cancer. T

      2/18/21 7:30:00 AM ET
      $ANAB
      $PFNX
      $ARCT
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Major Pharmaceuticals

    Pfenex Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Pipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors

      Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for precision neuroregeneration, today announced the appointment of Evert (Eef) Schimmelpennink to its Board of Directors. Mr. Schimmelpennink is a seasoned biotechnology executive with close to 25 years of experience spanning research and development, commercial growth, manufacturing, and business development. "I am pleased to welcome Eef Schimmelpennink to Pipeline's Board of Directors," said Carmine Stengone, President and Chief Executive Officer of Pipeline Therapeutics. "Eef is a renowned leader in the life-sciences industry whose cross-functional leade

      2/15/22 8:00:00 AM ET
      $IBIO
      $PFNX
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Major Pharmaceuticals